Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Value · MFS

NYLI WMC Value Fund Class A (MAPAX)

Ticker MAPAX · Since 1999-06-09 · · Holdings as of Jul 31, 2026

Expense ratio
1.02%$102/yr per $10k
5-yr return
+9.4%annualized
1-yr return
+8.1%as of Dec 2025
Net assets
$902.5Mall share classes
Holdings
66

Bottom line

Is MAPAX a good fund? The bottom line

MAPAX is the Class A share class of NYLI WMC Value Fund, a managed large value mutual fund from MFS.

It charges 1.02% — about $102 a year on every $10,000 invested, more expensive than 68% of large value funds we track.

It returned +8.1% over one year, +9.4% a year over five years, +11.1% a year over ten (as of Dec 31, 2025, per its prospectus).

With $903 million in net assets and 66 holdings, its largest position is Microsoft Corp. (6.6%) and the top 10 make up 26.8% of the portfolio.

This share class carries a front-end sales charge of up to 5.5%; a no-load class or ETF alternative can avoid it.

What to watch

  • Front-end sales load up to 5.5%
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What MAPAX invests in

The Fund seeks long-term appreciation of capital.

"The Fund invests in equity securities issued by companies of any size or market capitalization range. While the Fund does not limit its investments to issuers within a particular capitalization range, it generally invests in large capitalization companies (as represented by the market capitalization range of the Russell 1000 Index, which ranged from $1 billion to $4.5 trillion as of December 31, 2025). The Fund may invest in securities of foreign issuers, including securities of emerging market country issuers. An issuer of a security is considered to be a U.S. or foreign issuer based on the issuer's ""country of risk"" (or similar designation) as determined by a third-party such as Bloomberg. Wellington Management Company LLP, the Funds Subadvisor (the Subadvisor), defines emerging market countries as those countries that are included in the MSCI Emerging Markets Index. The Fund may…

From the fund's prospectus (filed Feb 26, 2026).

MAPAX performance

Average annual total returns
1 yr5 yr10 yr
MAPAX+8.1%+9.4%+11.1%
Large Value median+13.6%+11.3%+10.2%

Source: Fund prospectus, as of Dec 31, 2025

Full MAPAX performance history →

What MAPAX costs

On a $10,000 investment, MAPAX's 1.02% expense ratio costs about $102 a year. The prospectus estimates $1,729 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.

See the full MAPAX fee table →

MAPAX top 10 holdings

#Holding% of fund
1Microsoft Corp.6.60%
2JPMorgan Chase & Co.3.57%
3Johnson & Johnson2.67%
4Merck & Co., Inc.2.51%
5Cisco Systems, Inc.2.19%
6UnitedHealth Group, Inc.2.19%
7Elevance Health, Inc.1.79%
8Diamondback Energy, Inc.1.78%
9Intercontinental Exchange, Inc.1.75%
10U.S. Foods Holding Corp.1.71%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 26.8% of the fund. See all top 25 holdings and asset mix →

Alternatives to MAPAX

More funds like MAPAX →

MAPAX FAQ

What is the expense ratio of MAPAX?
MAPAX's expense ratio is 1.02%, which works out to about $102 a year for every $10,000 invested. The prospectus estimates total costs of $1,729 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MAPAX a good investment?
It depends on your goals, but the data points to: front-end sales load up to 5.5%; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does MAPAX hold?
MAPAX's largest holdings are Microsoft Corp. (6.6%), JPMorgan Chase & Co. (3.6%), Johnson & Johnson (2.7%), Merck & Co., Inc. (2.5%), Cisco Systems, Inc. (2.2%). It holds 66 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is MAPAX's 5-year return?
MAPAX returned +9.4% a year over the five years ending Dec 31, 2025, and +11.1% a year over ten years. Past performance does not guarantee future results.
Does MAPAX have a sales load?
Yes. MAPAX has a maximum front-end sales charge of 5.5%.
Who manages MAPAX?
MAPAX is offered by MFS through New York Life Investments Funds.